Order Article Reprints

Komleva YK, Potapenko IV, Lopatina OL, Gorina YV, Chernykh A, Khilazheva ED, Salmina AB, Shuvaev AN. NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer’s Disease. International Journal of Molecular Sciences. 2021; 22(21):11588. https://doi.org/10.3390/ijms222111588

Komleva, Yulia K., Ilia V. Potapenko, Olga L. Lopatina, Yana V. Gorina, Anatoly Chernykh, Elena D. Khilazheva, Alla B. Salmina, and Anton N. Shuvaev. 2021. "NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer’s Disease" International Journal of Molecular Sciences 22, no. 21: 11588. https://doi.org/10.3390/ijms222111588

Komleva, Y. K., Potapenko, I. V., Lopatina, O. L., Gorina, Y. V., Chernykh, A., Khilazheva, E. D., Salmina, A. B., & Shuvaev, A. N. (2021). NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer’s Disease. International Journal of Molecular Sciences, 22(21), 11588. https://doi.org/10.3390/ijms222111588